| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000023198 |
| Receipt No. | R000026690 |
| Official scientific title of the study | Imaging and epigenetic study for the therapeutic mechanism of ECT in the treatment of referactory depression |
| Date of disclosure of the study information | 2016/07/25 |
| Last modified on | 2016/07/16 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Imaging and epigenetic study for the therapeutic mechanism of ECT in the treatment of referactory depression | |
| Title of the study (Brief title) | Imaging and epigenetic study of ECT | |
| Region |
|
|
| Condition | ||
| Condition | Refractory depression | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To elucidate the therapeutic mechanism of ECT in the treatment of refractory depressin using functional connectivity measured by fMRI and DNA methylation. |
| Basic objectives2 | Others |
| Basic objectives -Others | To develop the prognostic biomarker in the treatment of feractory depressin in response to ECT |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Hamilton rating scale for depression
Functinal connectivity analysis DNA methylation Outcome measurement is done 1 day and 3 months after the final ECT. |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Electoric convulsive therapy
(Twice/week, Total 10 times, Duration 5 weeks) |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with major depression diagnosed by DSM-V and MINI. They did not respond to appropriate antidepressant treatments. | |||
| Key exclusion criteria | Patients with major depression and other psychiatric disorders.
Patients with major organic brain disorders. Patients who did not met ECT criteria due to physical illness. |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Shigeru Morinobu |
| Organization | Kochi University |
| Division name | Dept. neuropsychiatry, Med. Sch. |
| Address | Kohasu, Oko-cho, Nankoku, Kochi |
| TEL | 088-880-2359 |
| smorinob@kochi-u.ac.jp | |
| Public contact | |
| Name of contact person | Shigeru Morinobu |
| Organization | Kochi University |
| Division name | Dept. Neuropsychiatry, Med. Sch. |
| Address | Kohasu, Oko-cho, Nankoku, Kochi |
| TEL | 088-880-2359 |
| Homepage URL | https://kochi.neuropsychiatry/ |
| smorinob@kochi-u.ac.jp | |
| Sponsor | |
| Institute | Department of Neuropsychiatry, Kochi Medical School, Kochi University |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Department of Neuropsychiatry, Kochi Medical School, Kochi University |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | Kochi University of Technology |
| Name of secondary funder(s) | No |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 高知大学病院(高知県)、高知工科大学(高知県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026690 |